Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-12

Clinical Trial Update: Efficacy and Safety of RTX-GRT7039 in Adult Subjects With Knee Osteoarthritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of RTX-GRT7039 in adults with knee osteoarthritis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RTX-GRT7039

Snippet

Sponsor: Grünenthal GmbH | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED | Results posted: 2025-08-12